Although the percent expression of N-cadherin remained similar in between COPD groups, we further noticed a substantially higher expression of N-cadherin in COPD-ES and CS groups than in the HC (P <001 and <0.05, respectively) and asthma (P <0.001 and <0.0001, respectively). This evidence concerns the gene CDH2 and chronic obstructive pulmonary disease.